Dmitry Druzhinsky Advances Long-Term Athlete Development Through MatchPoint NYC's Training Infrastructure

Dmitry Druzhinsky, co-founder of MatchPoint NYC, continues to build the organization's training infrastructure as part of a long-term strategy focused on athlete development.

NEW YORK, Sept. 11, 2026 /PRNewswire/ -- The strategy centers on long-term athlete development, emphasizing consistent preparation, progressive skill development, and the physical foundation athletes need as they advance to higher levels of competition. Rather than measuring development only through immediate tournament results, the approach focuses on what athletes can achieve over several years.

The expansion of MatchPoint NYC's training infrastructure supports this strategy by providing athletes with an environment for continued technical, physical, and performance development. Training spaces, conditioning resources and performance monitoring capabilities are intended to support athletes at different stages of their development and help coaches evaluate progress over time.

For Dmitry Druzhinsky, developing the next generation of athletes means investing in their potential before their future achievements are known. A strong training base can give young athletes the opportunity to build skills gradually, gain competitive experience and develop the consistency required for higher-level sport.

"Long-Term Athlete Development is an investment in the future," said Dmitry Druzhinsky. "The goal is to create the conditions in which athletes can develop their abilities over time and have the training environment they need to pursue increasingly ambitious goals."

The organization's focus on developing its own athletes also creates a longer-term measure of the effectiveness of its training strategy and infrastructure. Athletes who progress through the system can ultimately show whether sustained investment in preparation and facilities translates into competitive results.

The Los Angeles 2028 Olympic Games provide an important milestone in that process. With Olympic preparation already underway, the period leading to LA28 offers an opportunity to evaluate training strategies, infrastructure and athlete development as the next generation of competitors moves toward the highest levels of competition.

For Dmitry Druzhinsky, however, LA28 represents one stage in a much longer process. The broader objective is to build a sustainable development system in which today's investment in training infrastructure and athlete preparation becomes tomorrow's competitive experience, achievements, and champions.

Press Release Service provided by 24-7PressRelease.com.

SOURCE MatchPoint NYC

Share this article

ARTICLE 32 PRELIMINARY HEARING SET IN CASE OF AIR FORCE MAJOR JASON P. WATSON

WASHINGTON, Sept. 11, 2026 /PRNewswire/ -- An Article 32 preliminary hearing in the case of United States v. Major Jason P. Watson is scheduled for Friday, September 18, 2026, at 1:30 p.m. EDT at Joint Base Anacostia-Bolling, Washington, D.C. Major Watson is represented by Monument Legal.

An Article 32 preliminary hearing is a proceeding under the Uniform Code of Military Justice that takes place before a case may be referred to a general court-martial. A neutral preliminary hearing officer reviews the charges to determine whether there is probable cause to believe an offense was committed and that the accused committed it, examines the form of the charges, and makes a recommendation about how the case should proceed. It is an early step in the military justice process, not a trial, and Major Watson is presumed innocent.

Members of the media and the public interested in attending should be aware that access to the installation and the hearing may require advance coordination, credentialing, and check-in, and that recording equipment and other items may be restricted. Those planning to attend are encouraged to make arrangements in advance.

About Monument Legal

Headquartered in Washington, DC, Monument Legal handles criminal defense, federal defense, and personal injury matters in the District of Columbia, Northern Virginia, and Lansing, Michigan. Founded in 2024 by Christopher J. Mutimer and Jay P. Mykytiuk, the firm represents clients in state and federal courts across all three markets. Learn more at monumentlegal.com.

SOURCE Monument Legal

Share this article

Engineering the Next Horizon: FAW TRUCKS Ready to Deliver in Hannover

HANNOVER, Germany, Sept. 11, 2026 /PRNewswire/ -- The 72nd IAA TRANSPORTATION will run from September 14 through September 20 at the Hannover Exhibition Grounds in Germany. Under the theme "Engineering the Next Horizon, Delivering the Next Journey" FAW TRUCKS will make a strong showing with five vehicle models, including the CORTRON CS600, and nine core assemblies—opening a dialogue between its historic legacy and its exploration of the future on the global commercial vehicle stage.

During the show, the five vehicles on display will together trace FAW TRUCKS's 70-year journey from its beginnings to industry leadership. The lineup will include three CORTRON CS tractors spanning diesel and battery-electric powertrain options. Developed for the long-haul transport market, the diesel models feature a new generation of core assemblies developed in-house, reducing vehicle fuel consumption by 15%. The battery-electric model is built on an 800 V high-voltage platform and supports dual-connector CCS2 fast charging at up to 1,000 A, with a single-connector Megawatt Charging System (MCS) available as an option. It also features a dual-motor e-axle with a peak transmission efficiency of 94.5%.

The stand will also feature nine core assemblies developed in-house, including the GD300 and ER540 Power Domains. Spanning multiple energy pathways—including conventional fuels, battery-electric power, and hydrogen—the lineup demonstrates FAW TRUCKS's strong in-house development capabilities.

Located at Stand B10, Hall 24, the FAW TRUCKS stand features an open-plan design with four themed zones: Low Carbon, Zero Carbon, Ecosystem, and Future. These zones respectively showcase advances in energy efficiency and carbon reduction for conventional powertrains, the new-energy product portfolio, full-lifecycle solutions, and cutting-edge technologies for next-generation intelligent logistics. Each exhibit has its own QR code, while detailed product information is also available on a dedicated microsite. By integrating the on-site and online experiences, FAW TRUCKS extends the exhibition beyond the boundaries of time and place.

At this year's exhibition, FAW TRUCKS will exhibit alongside partners including FAWER, FAWAY, FAWSN, SmartLink, and Zhuoyu Technology. Together, they will showcase FAW TRUCKS's transformation from operating solely as a manufacturer to becoming an integrated "products + services + ecosystem" solutions provider, while creating a platform for deeper engagement with customers and the wider industry ecosystem worldwide. Looking ahead, FAW TRUCKS will remain committed to independent technology development, continue advancing its core capabilities in multi-energy powertrains and intelligent connectivity, expand the global reach of Chinese commercial vehicles, and contribute to the high-quality development of the global transport industry.

SOURCE FAW TRUCKS

Share this article

LOS ANGELES, Sept. 11, 2026 /PRNewswire/ -- Accelevate Solutions and Brand Engagement Network, Inc. ("BEN") (Nasdaq: BNAI) today announced the launch of a live AI-powered passenger engagement platform for off-airport parking and shuttle services at Los Angeles International Airport (LAX). The platform introduces a real-time media and engagement layer that connects riders, operators, and brands.

Passengers can view routes, live vehicle locations, and estimated arrival times directly in the mobile experience. The BEN AI engagement layer is now live, with promotional and static advertising available immediately. Live paid advertising is expected to begin in Q4 2026.

The platform combines Accelevate Solutions' MobilityConnect™ fleet and audience-intelligence capabilities with BEN's AI engagement technology, delivered through the Mydas enterprise media platform. Connected-vehicle data, including data from Xirgo Technologies, powers the vehicle layer. Together, the solution enables transportation and transit operators to convert existing connected assets into a real-time engagement channel and, once advertising inventory is sold, a new revenue stream.

LIVE VEHICLE INTELLIGENCE • PASSENGER ENGAGEMENT • CONTEXTUAL MEDIA • MEASURABLE DELIVERY

For passengers, the experience delivers route visibility, real-time vehicle context, and AI-enabled engagement through a mobile client - no app download required and no added friction. Riders stay informed and engaged throughout their journey.

For operators, MobilityConnect adds a digital engagement layer to existing transportation services without replacing core fleet systems.

For brands, it creates a measurable channel grounded in real-world mobility context rather than disconnected digital impressions, helping deepen passenger engagement while supporting brand trust, loyalty, and repeat business.

Management Commentary

"We believe this is a transformational moment for transit operators," said James Maury, President and Co-Founder of Accelevate Solutions. "With AI-powered rider and location intelligence, operators can turn assets already in motion into real-time engagement and media channels - improving the passenger experience while opening new revenue opportunities. Combining our fleet and rider intelligence, real-time mobile engagement client, and our partner's automated cloud media stack will enable rapid adoption through Q1 2027.

MobilityConnect gives passengers live vehicle locations and estimated arrival times while providing operators with a new engagement channel on assets already in service. Paid campaigns are not yet live; the media layer is currently enabled with static loyalty promotions, and new advertising inventory can be sold from this point forward."

"Our partnership with Accelevate reflects our continued execution to scale our joint AI capabilities," said Tyler Luck, Chief Executive Officer of Brand Engagement Network. "BEN remains fully committed to supporting Accelevate's airport expansion across the United States and into public-sector opportunities in Latin America."

Ownership

BEN holds a minority interest in Accelevate. Following the Company's previously disclosed $1 million strategic investment and related warrant arrangements, BEN's ownership is expected to be approximately 20%. Accelevate is not consolidated under U.S. GAAP, and Accelevate revenue is not recognized as BEN revenue.

About Accelevate Solutions

Accelevate Solutions is a provider of AI-powered asset intelligence and engagement software for connected fleets. Its MobilityConnect® platform transforms connected asset and operational data into actionable intelligence, real-time customer engagement, and monetization opportunities, helping organizations improve asset utilization, automate decision-making, enhance customer experiences, and improve the financial performance of assets in motion. For more information, visit www.accelevatesolutions.com.

About Brand Engagement Network

Brand Engagement Network, Inc. ("BEN") builds secure, enterprise-grade artificial intelligence for the engagement layer of AI—where human intent is transformed into intelligent interactions, automated workflows, and real-world outcomes. Powered by BEN's proprietary Engagement Language Model (ELM™), the technology enables conversational AI interactions that connect human intent to organizational data, workflows, and real-world outcomes. BEN's AI operates within secure closed-loop environments using approved organizational data and built-in governance and compliance controls. Trusted by organizations in regulated and high-impact industries, BEN helps bring AI into real operational settings where engagement drives outcomes and accountability matters.

In June 2026, BEN acquired Cataneo GmbH, which provides enterprise software for advertising sales, scheduling, traffic, content management, monetization, analytics, CRM integration, and real-time reporting across linear, digital, and on-demand media. Cataneo supports advertising operations across more than 1,000 media brands and 200+ channels globally.

For more information, visit www.brandengagementnetwork.com.

Contacts

Accelevate Solutions Media: [email protected]

BEN Media: [email protected]

BEN Investor Relations: [email protected]

Forward-Looking Statements

Certain statements in this press release are "forward-looking statements" within the meaning of the federal securities laws, including statements regarding the LAX shuttle and parking deployment; the enabled media and engagement layer; the timing or sale of paid advertising; additional U.S. airport work; and BEN's business strategy and deployment activities. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Risks include, but are not limited to, the parties' ability to maintain live operations at LAX; convert an enabled media layer into sold campaigns; execute additional airport arrangements, which may not close on the expected timeline or at all; develop, integrate and deploy the contemplated solutions; achieve operator, passenger and advertiser adoption; protect data and systems; competition; financial performance; liquidity; Nasdaq listing; ongoing litigation; and other risks described in BEN's filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2025, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and subsequent filings. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date made. BEN undertakes no obligation to update or revise any forward-looking statements except as required by applicable law.

SOURCE Brand Engagement Network, Inc. (BEN)

Share this article

Invisors named one of the UK's Best Workplaces in Consulting and Professional Services™ 2026

GLASGOW, Scotland, Sept. 11, 2026 /PRNewswire/ -- Invisors, a Workday services provider, has officially been named one of the UK's Best Workplaces in Consulting and Professional Services™ 2026 by Great Place to Work®, the global authority on workplace culture, in the Small & Medium Organisation category on this year's list. This is Invisors' second inclusion in the Consulting and Professional Services category – earning a spot on this list is a wonderful achievement and a testament to the team in the UK. Learn what sets Invisors apart in the industry at invisors.com/company-overview.

Invisors' employees anonymously reported that the culture of inclusivity and flexibility makes the company a great place to work. When surveyed 92% of employees at Invisors say it is a great place to work*, compared to 54% of employees at a typical UK based company.

"This recognition means so much because it comes directly from our people, not from us. We've always believed that if we take care of our team, through trust, flexibility and genuinely listening to what they need, they'll do extraordinary work for our clients. Being named one of the UK's Best Workplaces in Consulting and Professional Services validates that the culture we've worked hard to build is real and it pushes us to keep raising the bar," said Matt Lawrence, EMEA Commercial Lead.

The Best Workplaces in Consulting and Professional Services™ award is based on anonymous surveys completed by Invisors employees, forming part of the wider Best Workplaces in Consulting & Professional Services™ list, which is created using anonymous feedback from employees working across the industry about their workplace experience. These firms cover a diverse range of knowledge-intensive roles, from legal services to management consultancy, engineering, marketing and advertising, telecoms, real estate, recruitment and travel management, to name a few.

Great Place to Work® UK administered its research-backed Trust Index© employee survey and analysed the responses of UK-based consulting and professional services employees to determine the Best Workplaces™ list. The survey asked employees to comment on how their company supports their work-life balance, sense of fulfilment, job satisfaction, psychological safety and financial security. Evaluations also included an assessment of how well the organisation was able to deliver consistency of employee experience across all departments and seniority levels.

"Our growth has always been about our people first. Every investment we make in flexibility, development and wellbeing is because we know that a supported team delivers better outcomes for our clients. This is Invisors' second time on this list and it's a proud milestone for our UK team — one we intend to build on," said Invisors EMEA Support AMS Lead, Lisa Duddy.

Benedict Gautrey, Managing Director of Great Place To Work® UK, said:

"The consulting and professional services sector continues to evolve rapidly, with organisations adapting to new technologies and changing client demands. In this environment, the very best workplaces recognise that supporting their people through periods of change is essential. Feedback from employees highlights the importance of transparent leadership, open communication, and involving people in decisions that affect them. These are the qualities that help employees feel valued, informed, and able to do their best work. Congratulations to Invisors on achieving UK's Best Workplaces in Consulting & Professional Services™ recognition and for fostering a workplace culture that puts its people first."

This year, Invisors has received several recognitions based on revenue, growth and employee-satisfaction, including UK's Best Workplaces for Women List, UK's Best Workplaces and Great Place To Work Certified in the UK. These recognitions reflect the strong culture we've built at Invisors and the values that guide our team. We're proud to prioritise our people and create an environment where they can thrive alongside our business. Explore the latest news, awards and recognition from Invisors at invisors.com/news.

About Invisors

As a certified Workday Services Partner, Invisors helps customers utilise their organisational data to make better-informed business decisions through the deployment of Workday. We believe the most important measure of our team's success is our clients' ability to achieve their big-picture vision. From initial deployments to ongoing projects, we are focused on elevating perspectives + transforming results. Learn more by visiting invisors.com.

About Great Place To Work®

Great Place To Work® is the global authority on workplace culture, on a mission to make every company a great workplace for all. Every year, they receive direct feedback from over 10 million workers around the world telling them how they really feel about their employer. Their survey is completely confidential and anonymous, so people can feel comfortable being honest about their workplace, and companies can gain detailed insights into how they can better serve their people.

Only those employers who have the highest levels of trust, job satisfaction, and who empower ALL their employees to thrive both in and outside of work are awarded official Best Workplaces™ recognition. For more information, visit greatplacetowork.co.uk.

SOURCE Invisors

Share this article

Valmet to publish its Interim Review for January - September 2026 on October 28, 2026

Valmet Oyj's press release on September 11, 2026 at 12:00 p.m. EEST

ESPOO, Finland, Sept. 11, 2026 /PRNewswire/ -- Valmet's Interim Review January – September 2026 will be published on Wednesday, October 28, 2026, at approximately 9:00 a.m. Finnish time (EET). The stock exchange release and presentation materials will be available on Valmet's website at www.valmet.com/investors.

Webcast

Valmet will host a results webcast in English as a live webcast at https://valmet.events.inderes.com/q3-2026 on Wednesday, October 28, 2026, at 9:30 a.m. Finnish time (EET).

A recording will be available shortly after the event at the same address.

Conference call

Participants may also join the news conference via a conference call by registering at:

https://events.inderes.com/valmet/q3-2026/dial-in

After registration, you will receive dial-in details and a conference ID. To ask a question during the call, please dial #5 on your telephone keypad.

All questions should be presented in English.

VALMET 

Corporate Communications 

For further information, please contact:

Pekka Rouhiainen, VP, Investor Relations, Valmet, tel. +358 10 672 0020

For media: Antti Ylitalo, Director, External Communications, Valmet, tel. +358 10 672 0000

Valmet is a global technology leader in serving process industries. We work with our customers throughout the lifecycle, delivering cutting-edge technologies and services, as well as mission-critical automation and flow control solutions. Backed by more than 225 years of industrial experience and a global team of 18,500 professionals close to customers, we are uniquely positioned to transform industries toward a regenerative tomorrow.

In 2025, Valmet's net sales totaled approximately EUR 5.2 billion. Our head office is in Espoo, Finland, and we have experts in approximately 40 countries around the world. Valmet's shares are listed on Nasdaq Helsinki.

Follow us on valmet.com | X | X (IR) | LinkedIn | Facebook | YouTube | Instagram |

This information was brought to you by Cision http://news.cision.com

Share this article

Cooling Mattress (2026): NELL Named for Japanese Craftsmanship and Breathable Sleep Design by Consumer365

NEW YORK, Sept. 11, 2026 /PRNewswire/ -- Consumer365 has named NELL in its 2026 cooling mattress coverage, looking closely at how the Japanese sleep brand uses dense pocket-coil construction and thin material layers to support airflow during the night. Cooling claims can refer to covers, gels, foams, or internal ventilation. The report also explains which parts of a mattress are responsible for managing heat over several hours of sleep.

Best Cooling Mattress:

- NELL - a Japanese sleep brand offering handcrafted pocket-coil mattresses designed for breathable, responsive support

The announcement follows NELL's first U.S. launch. Founded in 2020, the company became Japan's leading direct-to-consumer coil mattress brand by 2025, based on direct-to-consumer coil mattress sales in the country. More than 220,000 customers have purchased from the brand, according to company information.

Why Did Consumer365 Recognize NELL?

Consumer365's coverage examines the NELL Mattress as an example of cooling design built around coil engineering rather than thick foam. A king-size model contains 4,704 individually wrapped pocket coils, approximately four times the 500 to 1,000 coils commonly found in mattresses, according to NELL.

Each coil responds independently to pressure. The system is configured with firmer support through the middle and perimeter, while the shoulder and hip areas provide more contouring. This construction is intended to distribute body weight, limit partner disturbance, and make it easier to turn during sleep.

The mattress also uses thin layers of foam and cotton. Air can pass around the coils and through these layers, helping heat and moisture leave the sleep surface.

Why Does Breathable Construction Matter?

Cooling mattress design depends partly on how materials manage body heat over several hours. Pocket coils leave open space inside the mattress, offering another path for air circulation.

NELL addresses several practical sleep needs:

- Airflow through the coil structure and thin comfort layers

- Responsive support without a deep sink-in sensation

- Independent coil action intended to limit motion transfer

- Firmer reinforcement through the middle and perimeter

How Is Japanese Craftsmanship Built Into the NELL Mattress?

NELL mattresses are handcrafted in Okawa, Fukuoka, a Japanese city with a long furniture-making history. Founder Koki Doi worked with local artisans and engineers while studying sleep science and mattress performance across a full night.

The development process included more than 300 spring prototypes. The final coil specification was calibrated in increments of 0.1 millimeter, and custom machinery was built specifically for its production.

Those details provide context for Consumer365's assessment. The mattress is engineered around long-term support, airflow, and durability rather than the first few seconds of softness experienced in a showroom.

How Does NELL Address Long-Term Ownership?

Mattress performance can change as foam softens and materials experience years of nightly use. NELL limits the amount of polyurethane foam in its design and relies primarily on a pocket-coil support structure intended to retain its form over time.

U.S. customers receive a 365-night home trial, with free collection available for eligible comfort-related returns after at least 14 nights. Each mattress also includes a lifetime warranty. Delivery is free throughout the United States except Alaska and Hawaii, where an additional fee applies.

What Does the U.S. Launch Mean for Mattress Buyers?

NELL's entry into the United States adds a Japanese-made option in twin, twin XL, full, queen, king, and California king sizes. Its design treats breathability as part of the internal structure, pairing individually wrapped coils with thin cotton and foam layers. Consumer365's coverage looks at how this construction helps manage heat, respond to pressure, and maintain support over time.

What Is the Main Takeaway?

NELL's inclusion in Consumer365's 2026 cooling mattress coverage places Japanese manufacturing and internal airflow within the same sleep-design discussion. The assessment offers a practical way to evaluate cooling claims by looking beneath the mattress cover and examining how construction affects heat management across an entire night. For U.S. shoppers, NELL offers another engineering-led option to the cooling mattresses currently available in the market.

For the full review, please visit the Consumer 365 website.

About NELL

NELL is a Japanese direct-to-consumer sleep brand founded in 2020. Its mattress is handcrafted in Okawa, Fukuoka, and uses a precision pocket-coil system. NELL entered the U.S. market with free delivery in most states, a 365-night home trial, and a lifetime warranty. More information is available at nellusa.com.

About Consumer365.org: Consumer365 provides consumer news and industry insights. As an affiliate, Consumer365 may earn commissions from sales generated using links provided.

SOURCE Consumer365.org

Share this article

Vizrt Named a Leader in the 2026 IDC MarketScape for Worldwide AI-Driven Business Cycle in the Media Industry

For Vizrt, the recognition highlights its vision for agentic AI that combines intelligent production orchestration with human editorial control

LONDON, Sept. 11, 2026 /PRNewswire/ -- Vizrt, the AI platform for visual storytelling, today announced it has been named a Leader in the IDC MarketScape: Worldwide AI-Driven Business Cycle in the Media Industry, 2026 Vendor Assessment.

The IDC MarketScape evaluates technology providers helping media organisations apply artificial intelligence across business and production workflows, assessing vendors against criteria including current capabilities, strategy, innovation and market execution. For Vizrt, it's recognition as a Leader reflects its growing focus on agentic AI and AI-orchestrated production environments designed specifically for the needs of broadcasters, content creators, and live production teams.

As artificial intelligence evolves beyond standalone tools toward intelligent systems capable of coordinating entire production workflows, broadcasters face increasing pressure to drive efficiency without compromising reliability, governance or editorial control. Media organisations need AI that can work across complex production environments while ensuring human oversight remains at the centre of decision-making, particularly in live, regulated and brand-sensitive contexts.

"Vizrt was recognized as a Leader in this IDC MarketScape for treating live production as a genuinely composable, agentic problem rather than a single point solution. The AI Production Director's orchestration of Viz Engine, Viz Artist, Viz One, Viz Mosart, and Viz Pilot through specialized agents reflects a level of platform innovation the industry needs," said Alex Holtz, Research Director, IDC MarketScape.

"We believe the next era of media production will be defined by how effectively organisations combine AI-driven automation with human creativity and editorial expertise. The opportunity isn't to remove people from the production process; it's to remove complexity. By enabling AI to orchestrate repetitive and time-consuming production tasks, creative teams can focus on storytelling, audience engagement, and delivering exceptional live experiences. Beyond removing complexity, AI lets creative teams craft differentiated visual experiences - graphics and narratives that adapt in real time to the audience, the moment, and the story being told. We're proud of our inclusion in the Leaders Category of the IDC MarketScape," said Rohit Nagarajan, Chief Executive Officer at Vizrt.

Vizrt's key strengths as noted by IDC MarketScape include:

- Composable agentic platform architecture is a clear differentiator: The AI Production Director orchestrates Viz Engine, Viz One, Viz Mosart, and Viz Pilot under a single orchestration layer via five specialized agents - Story Producer, Asset Discovery, Graphics Intelligence, Data Storyteller, and Distribution. A knowledge base agent plus customer-owned operational preference memory captures show conventions, editorial voice, brand rules, and production patterns so agents reproduce shows the way experienced operators would. The pitch is explicit: these competencies cannot be replicated individually without acquisition or deep partnership.

- Open standards posture is concrete rather than tracked: Vizrt has adopted MCP for agent interoperability and participates in JT-DMF, MXL, and OGraf working groups - among the more forward-leaning standards postures in the assessed cohort. API-first architecture supports cloud, on-prem, and hybrid AI infrastructure, positioning Vizrt as an integration point for software-defined production environments rather than a closed silo.

- Production-tested credibility on the demanding side of live broadcast, with specialist sports IP: Viz Engine has earned trust across the most demanding live broadcasts; AI Keyer won Best of Show at NAB 2026 - production-grade reference points that close credibility gaps newer entrants cannot match. Sports production fit is reinforced by Viz Libero, Viz Arena, and virtual advertising paired with the AI Production Director's multiplatform output - aligned tightly with sports rights holders monetizing across broadcast, OTT, and social.

To learn more about Vizrt's recognition and access the IDC MarketScape profile excerpt, visit https://go.vizrt.com/vizrt-idc-marketscape-leader-ai.

Source: IDC MarketScape: Worldwide AI-Driven Business Cycle in the Media Industry, # US54113826, September 2026.

Notes to Editors

About Vizrt

Founded in 1997, Vizrt is a leading viewer engagement platform and a trusted expert in live production technologies for the Media & Entertainment, Sports, Enterprise, and Content Creator industries.

Vizrt's platform for AI-led visual storytelling is the foundation for a new era of content creation, enabling creators to streamline workflows and enhance content delivery. It offers solutions for every component of live production, from real-time data-driven graphics and studio automation to intelligent media asset management and cloud-based productions.

Vizrt, and its subsidiary NDI, employs over 600 people globally, enabling thousands of organizations worldwide, from colleges and corporates to the largest names in news and sport, to deliver visually immersive experiences to billions of people daily. For more information, visit https://vizrt.ai.

About IDC MarketScape

IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of technology and service suppliers in a given market. The research utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each supplier's position within a given market.

IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of technology suppliers can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective suppliers.

Share this article

Munters completes expansion of data center cooling campus in Daleville, Virginia

STOCKHOLM, Sept. 11, 2026 /PRNewswire/ -- Munters, a global leader in technologies that optimize climates, this week inaugurated its expanded campus for data center cooling in Daleville, Virginia. With additional space for manufacturing, training and testing, the investment enables Munters to produce customized cooling solutions at scale and contribute to a resource-efficient build-out of digital infrastructure.

With close to 600 current employees and a site covering 565,000 square feet (52,000 m²)., The Daleville campus is the largest of five dedicated manufacturing facilities within Munters business area Data Center Technologies globally. It produces all of the products in Munters broad data center cooling portfolio: Air side economizers, the patented SyCool Split, CRAHs (computer room air handling units), fan coil arrays, CDUs (coolant distribution units) and now also chillers.

The expanded site also houses the Munters Service Academy, new production test stands and a chiller laboratory with an advanced environmental chamber. Find out more about Munters data center campus in Virginia here.

"The rapid growth of AI and high-performance computing is creating new demands not only for digital infrastructure, but also for the energy, water and physical infrastructure that supports it. With these new capabilities we are well positioned to deliver on our ambitious growth agenda while meeting the needs of customers and communities," says Stefan Aspman, President of Munters Data Center Technologies.

"Having the right manufacturing setup is only part of the equation. We also need skilled people, technical knowledge and service capabilities to support our customers with solutions that operate effectively and with a minimum waste of resources throughout their lifetime," adds Frank Pellegrino, SVP Sales & Strategy for DCT and incoming President of the business area.

The expansion of the Daleville facility has enabled Munters to launch local manufacturing of chillers, which were previously produced in Italy. This includes the Circlemiser chiller which - thanks to innovative design elements including its cylindrical condensing coils - greatly reduces energy consumption and total required power compared to typical air-cooled chillers.

For more information: 

Line Dovärn, Head of Investor Relations 

E-mail: [email protected], Mobil: +46 (0)73 048 844

Media:

Daniel Frykholm, Vice President External Relations and Internal Communication

E-mail: [email protected], Phone: +46 (0)702 067 786

This information was brought to you by Cision http://news.cision.com

The following files are available for download:

SOURCE Munters Group AB

Share this article

The U.S. FDA grants orphan drug designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for treatment of endogenous Cushing's syndrome

- The U.S. FDA has granted Orphan Drug Designation for asedebart (Lu AG13909), Lundbeck's novel investigational anti-ACTH monoclonal antibody, for the treatment of endogenous Cushing's syndrome

- Endogenous Cushing's Syndrome is a rare endocrine disorder driven in most cases by excess adrenocorticotropic hormone, or ACTH, leading to chronic cortisol excess and substantial disease burden, with current treatment options often limited by suboptimal disease control and treatment-related complications 1–3

- Proof-of-concept trial currently ongoing to evaluate efficacy and safety of Lu AG13909 in Cushing's disease (CD)5

VALBY, Denmark, Sept. 11, 2026 /PRNewswire/ -- Lundbeck today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to asedebart (Lu AG13909), Lundbeck's novel investigational anti-ACTH monoclonal antibody, for the treatment of endogenous Cushing's syndrome.

Endogenous Cushing's syndrome includes both ACTH-dependent and ACTH-independent forms. ACTH-dependent Cushing's syndrome is a rare, serious endocrine disorder caused by excess secretion of adrenocorticotropic hormone (ACTH), most commonly from a pituitary tumor (Cushing's disease) and less frequently from an ectopic ACTH-secreting tumor.1 Elevated ACTH drives increased adrenal production of glucocorticoids, mineralocorticoids and androgens, disrupting normal physiological homeostasis. Of particular importance is sustained cortisol excess, which contributes to a considerable disease burden through metabolic, cardiovascular and neuropsychiatric complications and is associated with increased morbidity and mortality.1,2 Although existing medical therapies can reduce or control elevated cortisol levels, important treatment gaps remain.1,3 Achieving and maintaining adequate disease control can be difficult, with available therapies differing in their efficacy and potentially constrained by safety and tolerability considerations.4

Asedebart is a novel investigational monoclonal antibody targeting ACTH and is being developed for ACTH-dependent Cushing's syndrome. It is advancing in clinical development as a potential first-in-class treatment for rare conditions characterized by excess ACTH, with proof-of-concept trials ongoing in CD and classic congenital adrenal hyperplasia (CAH) to evaluate efficacy and safety.5–8

With this designation, asedebart continues to build momentum with regulatory authorities across rare ACTH-driven disorders. Asedebart has also received orphan designation in the European Union for Cushing's syndrome of endogenous origin, in addition to previous orphan drug designations for CAH in the European Union and the United States, and for CAH and CD in Japan.6,9,10

"The FDA Orphan Drug Designation is an important step for asedebart and for Lundbeck's growing commitment to rare neuroendocrine disorders," said Tarek Samad, Executive Vice President and Head of Research & Development at Lundbeck. "ACTH-dependent Cushing's syndrome can be a devastating condition for patients, with long-term consequences that remain difficult to control despite available treatments. This milestone reflects the strength of the science behind asedebart's development to date and supports our ambition to advance innovative medicines in areas where patients continue to face significant unmet need."

Orphan Drug Designation is granted by the US FDA to drugs and biologics intended to treat, diagnose or prevent rare diseases or conditions. The designation may provide certain development incentives, including tax credits for qualified clinical testing, exemption from certain FDA application fees and, if approved, potential seven years of market exclusivity for the designated indication.11

Asedebart is an investigational compound that is not approved for marketing by any regulatory authority worldwide, and its efficacy and safety have not been established.

About asedebart

Asedebart is a humanized anti-ACTH monoclonal antibody that specifically recognizes ACTH with high affinity. It blocks the binding of ACTH to the melanocortin 2 receptor in the adrenal glands and thereby inhibits the neurohormonal signalling of ACTH. This inhibition reduces secretion of glucocorticoids, mineralocorticoids and androgens from the adrenal glands.12,13

ACTH plays a key role in the biosynthesis of adrenal steroids13 and is therefore considered a promising therapeutic target in conditions characterized by elevated ACTH levels. Through its mechanism of action, asedebart has the potential to treat conditions associated with chronically elevated ACTH levels, such as CD and CAH.

About ACTH-dependent Cushing's syndrome

ACTH-dependent Cushing's syndrome is a rare, serious endocrine disorder caused by excess secretion of adrenocorticotropic hormone (ACTH), most commonly from a pituitary tumor (Cushing's disease) and less frequently from an ectopic ACTH-secreting tumor.1 Chronic cortisol excess is associated with substantial disease burden, including metabolic, cardiovascular and neuropsychiatric complications, and is linked to increased morbidity and mortality.1,2 Surgery to remove the source of excess ACTH is the preferred first-line treatment when feasible; however, not all patients are eligible for surgery or achieve sustained remission. Current medical therapies can help manage cortisol excess, but disease control remains challenging and treatment options may be limited by variable efficacy, safety and tolerability.1,3

Contacts

About H. Lundbeck A/S

Lundbeck is a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases.

Brain disorders affect a large part of the world's population, and the effects are felt throughout society. With the rapidly improving understanding of the biology of the brain, we hold ourselves accountable for advancing brain health by curiously exploring new opportunities for treatments.

As a focused innovator, we strive for our research and development programs to tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.

We are committed to fighting stigma and we act to improve health equity. We strive to create long term value for our shareholders by making a positive contribution to patients, their families and society as a whole.

Lundbeck has more than 5,000 employees in more than 20 countries and our products are available in more than 80 countries. For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us via LinkedIn.

References:

- Nieman LK. ACTH-Dependent Cushing's Syndrome: Pathophysiology. Endocr Rev. 2022;43(2):117–171.

- Fleseriu M, et al. Consensus on diagnosis and management of Cushing's disease. Lancet Diabetes Endocrinol. 2021;9(12):847–875.

- Nieman LK, et al. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(8):2807–2831.

- Julia Simões Corrêa Galendi, et al. Effectiveness of Medical Treatment of Cushing's Disease: A Systematic Review and Meta-Analysis. Front Endocrinol 2021;12:732240.

- ClinicalTrials.gov. A Trial of Lu AG13909 in Adult Participants With Cushing's Disease, BalanCeD. NCT06471829.

- Lundbeck. Data on file.

- Johannsson G, Velusamy A, Prete A, et al. MON-468: A Novel Anti-ACTH Antibody Lu AG13909 in Clinical Development for Treatment of Classic Congenital Adrenal Hyperplasia: A Phase 1 Open-Label, Multiple-Ascending-Dose Study. Journal of the Endocrine Society. 2025;9(Suppl 1):bvaf149.226.

- Srirangalingam U, Prete A, Frederiksen T, et al. SAT-455: A Phase 2, Open-Label Trial Evaluating the Efficacy and Safety of Anti-ACTH Antibody Lu AG13909 in Adults With Classic Congenital Adrenal Hyperplasia: Trial Design. Journal of the Endocrine Society. 2025;9(Suppl 1):bvaf149.323.

- Lundbeck. Lundbeck receives orphan drug designation in the US and EU for Lu AG13909 for the treatment of congenital adrenal hyperplasia. 24 June 2025.

- Lundbeck. Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease. 18 May 2026.

- U.S. Food and Drug Administration. Designating an Orphan Product: Drugs and Biological Products.

- Feldhaus AL, et al. ALD1613, a Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven Pharmacology. Endocrinology. 2017;158(1):1–8.

- Xing Y, et al. The effects of ACTH on steroid metabolomic profiles in human adrenal cells. J Endocrinol. 2011;209(3):327–335.

CONTACT:

H. Lundbeck A/S

Ottiliavej 9, 2500 Valby, Denmark

+45 3630 1311

[email protected] 

This information was brought to you by Cision http://news.cision.com

The following files are available for download:

Share this article